Welcome to Abdul Latif Jameel Health Saudi Arabia

ABOUT US

Abdul Latif Jameel Health
Accelerating access adding value

We are committed to adding real, tangible value, not only to all our business partner relationships but also to communities within Saudi Arabia.

As a solutions partner, we strongly believe in success through service – working together with stakeholders; taking a structured, systemic, focus to delivering on our promises.

With this approach, we are accelerating access to modern medical care for more people in more places and for those that need it most.

about-us img

Who we are

Abdul Latif Jameel Health Saudi Arabia was founded in 2020, as our response to one of the greatest challenges of healthcare – the disparity in access to modern medical care, notably in the fast-growing market, remote territories, and economy within Saudi Arabia in line with the National Transformation Program of the Kingdom’s 2030 vision.

Backed by Abdul Latif Jameel Enterprises, – one of the regions most respected diversified family businesses and investors, with a 75-year heritage, deep roots and established networks and a multi-sector presence in 30 countries across six continents – Abdul Latif Jameel Health Saudi Arabia is uniquely positioned as a trusted partner to realize the exciting opportunities ahead.

Our approach

Abdul Latif Jameel Health Saudi Arabia builds on the Jameel family’s long-established philanthropy, Community Jameel, and its’ focus on innovating for a better future by seeking to solve problems at source.

This includes the co-founding of the Abdul Latif Jameel Clinic for Machine Learning in Health (Jameel Clinic) at MIT and the Abdul Latif Jameel institute for Disease & Emergency Analytics (Jameel Institute) at Imperial College London.

Abdul Latif Jameel Health Saudi Arabia takes this philosophy into the commercial environment addressing tangible real-world needs today – for a better tomorrow.

WHAT WE DO

Harnessing key trends as drivers of success

We are continually exploring emerging trends and innovation in technology, therapeutics and business models to accelerate access to modern medical care in growing markets and developing economies.

Technology adoption

The rapid innovation cycle in global health technology , including AI, robotics, therapeutics, medical devices, regenerative medicine and more, presents significant opportunities.

This is impacting drug and device filing, registration and market authorization as well as licensing arrangements.

We seek to both invest in emerging ideas and connect businesses to new growth opportunities particularly in rapidly developing markets.

National Health security

Increasing resilience in our society’s healthcare systems and processes to increase public and private health security has become a pressing need

With our international and local network, we are uniquely positioned to be a key player in this emerging environment helping our partners to deliver and realizing our overarching goal of expanding access and enhancing resilience and business continuity to modern health care.

Localization – local partnerships

Tailoring health solutions to local markets is a key pre-requisite for success. Government endorsement and incentives to promote local manufacturing are driving momentum and a rising investment in local manufacturing.

This includes more rapid approval processes for innovative medicines; technology assessment and approval, and more structured clinical guidelines. We are able to navigate these new opportunities, benefiting our partners and the community.

Expansion of healthcare coverage

There is a growing commitment of government to widen and diversify national health coverage policies.

In parallel, growing demand for health insurance coverage continues to demand innovative funding models.

In turn this requires the expansion of the role of Public-Private Partnership models in healthcare to enable access, where we are ready and able to play an enabling role

Patient centricity

Increasing patient centricity continues to drive the importance of patient education and support programs.

We are ready to play our role in enabling individuals to take an active interest in their own health management.